Nuwellis (NUWE) FCF Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | 20,435.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,435.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,242.00 |
| Jun 30, 2025 | 5,665.00 |
| Mar 31, 2025 | 12,106.00 |
| Dec 31, 2024 | 18,899.00 |
| Sep 30, 2024 | 14,129.00 |
| Jun 30, 2024 | 2,892.00 |
| Mar 31, 2024 | 12,784.00 |
| Dec 31, 2023 | 6,469.00 |
| Sep 30, 2023 | 7,490.00 |
| Jun 30, 2023 | -7,752.00 |
| Mar 31, 2023 | 306.00 |
| Dec 31, 2022 | 16,221.00 |
| Sep 30, 2022 | 14,225.00 |
| Jun 30, 2022 | 6,508.00 |
| Mar 31, 2022 | 15,299.00 |
| Dec 31, 2021 | -7,210.00 |
| Sep 30, 2021 | 598.00 |
| Jun 30, 2021 | 16,348.00 |
| Mar 31, 2021 | 20,760.00 |
| Dec 31, 2020 | 21,433.00 |
| Sep 30, 2020 | 10,184.00 |
| Jun 30, 2020 | 29,695.00 |
| Mar 31, 2020 | -15,903.00 |
| Dec 31, 2019 | 7,005.00 |
| Sep 30, 2019 | 52,916.00 |
| Mar 31, 2018 | 1.16 Mn |
| Dec 31, 2017 | 268,337.00 |
| Sep 30, 2017 | 902,916.00 |
| Mar 31, 2017 | 1.12 Mn |
| Sep 30, 2016 | 637,149.00 |